期刊文献+

溴吡斯的明口腔崩解片的研制及质量控制 被引量:1

Preparation and Quality Control of Pyridostigmine Bromide Orally Disintegrating Tablet
原文传递
导出
摘要 目的制备口感良好的溴吡斯的明口腔崩解片,并优化处方。方法采用溶剂蒸发-沉积法制备固体分散体掩盖药物苦味,以崩解时间为指标,采用星点设计-效应面法优化处方。结果制备的口腔崩解片表面完整光洁,口感良好,能在30s内崩解完全。在水中0.5min内的药物溶出率约为8.5%,释药量约为2.5mg,低于苦味阈值(约3mg);在0.1mol/L盐酸介质中,2min累积溶出率大于95%。结论制备的口腔崩解片处方合理,工艺可行,方便患者服用。 Objective To prepare orally disintegrating tablets containing pyridostigmine bromide and optimize formulations.Methods Solid dispersion was prepared using solvent evaporation-deposition method.The formulation was optimized by central composite design-response surface methodology(RSM plus CCD) with disintegration time as a reference parameter.Results The orally disintegrating tablets showed integrity and were smooth with desirable taste and feel in mouth.The disintegration time was less than 30 s.The cumulative drug dissolution was around 8.5%(around 2.5 mg which was less than bitterness threshold of pyridostigmine bromide of 3 mg) within 5 min in water while the cumulative drug dissolution was higher than 95% within 2 min in 0.1 N HCl.Conclusion The orally disintegrating tablets are reasonable in formulation,feasible in technology and patient-friendly.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第3期458-461,477,共5页 Journal of Sichuan University(Medical Sciences)
基金 教育部博士点基金(20095503120008) 重庆市教育委员会(首批高等学校优秀人才资助,KJ090308)资助
关键词 溴吡斯的明 星点设计 效应面法 口腔崩解片 Pyridostigmine bromide Central composite design Response surface methodology Orally disintegrating tablet
  • 相关文献

参考文献7

  • 1Fu Y,Yang S,Jeong SH,et al.Orally fast disintegratingtablets:developments,technologies,taste-masking and clinicalstudies.Crit Rev Ther Drug Carrier Syst,2004;21(6):433-476.
  • 2Chris T.A review of myasthenia gravis:pathogenesis,clinicalfeatures and treatment.Curr Anaesth Crit Care,2007;18(1):15-23.
  • 3Zhao B, Moochhala SM, Lu J, et al. Determination of pyridostigmine bromide and its metabolites in biological samples. J Pharm Sci,2006;9(11):71-81.
  • 4Zimerman LI,Liberman A,Castro RR,et al.Acuteelectrophysiologic consequences of pyridostigmine inhibition ofcholinesterase in humans.Braz J Med Biol Res,2010;43(2):211-216.
  • 5毛叶萌,张奇志,钱景时,沈洁净,李琦,蒋新国.阿普唑仑口腔崩解片的制备及质量评价[J].中国药学杂志,2009,44(1):36-39. 被引量:9
  • 6周云飞,王柏.星点设计-效应面法优化盐酸氨溴索缓释片处方[J].中国药科大学学报,2007,38(1):39-42. 被引量:22
  • 7张梨,谭群友,陈亮,柳珊,赵春景,张景勍.溴吡斯的明-β-环糊精包合物的研制[J].中国医院药学杂志,2010,30(6):466-470. 被引量:14

二级参考文献23

共引文献42

同被引文献24

  • 1溴吡斯的明β-环糊精包合物分散片的研制及质量控制[J].中国医药工业杂志,2011,42(5):351-354. 被引量:4
  • 2伊春芳,王东凯.多西紫杉醇白蛋白微球的制备及性质[J].中国药剂学杂志(网络版),2014,12(5):160-166. 被引量:4
  • 3Sieb JP,K?hler W.Retardiertes pyridostigminbromid in der myasthenie-behandlung ergebnisse einer nicht-interventionellen beobachtungsstudie[J].Akt Neurol,2009,36(1):4.
  • 4Sieb JP,K?hler W.Benefits from sustained-release pyridostigmine bromide in myasthenia gravis:results of a prospective multicenter open-label trial[J].Clin Neurol Neurosurg,2010,112(9):781.
  • 5Hegazy N,Demirel M,Yazan Y.Preparation and in vitro evaluation of pyridostigmine bromide microparticles[J].Int J Pharm,2002,242(1/2):171.
  • 6Huang YT,Tsai TR,Cheng CJ,et al.Formulation design of a highly hygroscopic drug(pyridostigmine bromide)for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties[J].Drug Dev Ind Pharm,2007,33(4):403.
  • 7Bolourchian N,Rangchian M,Foroutan SM.Prolonged release matrix tablet of pyridostigmine bromide:formulation and optimization using statistical methods[J].Pak J Pharm Sci,2012,25(3):607.
  • 8Huang YT,Tsai TR,Cheng CJ,et al.Formulation design of an HPMC-Based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties[J].Drug Dev Ind Pharm,2007,33(11):1 183.
  • 9Tan Q,Jiang R,Xu M,et al.Nanosized sustained-release pyridostigmine bromide microcapsules:process optimization and evaluation of characteristics[J].Int J Nanomedicine,2013,doi:10.2147/IJN.S40860.
  • 10Tan QY,Xu ML,Wu JY,et al.Preparation and characterization of poly(lactic acid)nanoparticles for sustained release of pyridostigmine bromide[J].Pharmazie,2012,67(4):311.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部